Showing results (31-40 of 87) with videos related to
Sort By:
Pageof 9
Oncotargets and Therapy|May 17, 2014
Stage-dependent prognostic impact of molecular signatures in clear cell renal cell carcinomaThomas Weber, Matthias Meinhardt, Stefan Zastrow, et al.Urology|December 15, 2004
Qualitative and quantitative assessment of urinary cytokeratin 8 and 18 fragments compared with voided urine cytology in diagnosis of bladder carcinomaOliver W Hakenberg, Susanne Fuessel, Katja Richter, et al.Plos One|August 6, 2024
Hot topic: Mapping of the human intranasal mucosal thermal sensitivity: A clinical study on thermal threshold and trigeminal receptorsSusanne Weise, Pauline Hanslik, Coralie Mignot, et al.International Journal of Molecular Sciences|May 14, 2022
Inhibition of Human Urokinase-Type Plasminogen Activator (uPA) Enzyme Activity and Receptor Binding by DNA Aptamers as Potential Therapeutics through Binding to the Different Forms of uPANico Dreymann, Julia Wuensche, Wiebke Sabrowski, et al.Journal of Cancer Research and Clinical Oncology|January 12, 2022
Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell linesLukas Donix, Holger H H Erb, Claudia Peitzsch, et al.Diagnostics (Basel, Switzerland)|August 14, 2020
Evaluation of MicroRNAs as Non-Invasive Diagnostic Markers in Urinary Cells from Patients with Suspected Prostate CancerAngelika Borkowetz, Andrea Lohse-Fischer, Jana Scholze, et al.The Journal of Urology|June 11, 2005
Vascular endothelial growth factor antisense pretreatment of bladder cancer cells significantly enhances the cytotoxicity of mitomycin C, gemcitabine and CisplatinSabine Krause, Yvonne Förster, Kai Kraemer, et al.Plos One|October 3, 2013
Analyses of potential predictive markers and survival data for a response to sunitinib in patients with metastatic renal cell carcinomaJuana Dornbusch, Aristeidis Zacharis, Matthias Meinhardt, et al.Journal of Biomedical Nanotechnology|April 16, 2014
Carbon nanofibers and carbon nanotubes sensitize prostate and bladder cancer cells to platinum-based chemotherapeuticsJessica Ringel, Kati Erdmann, Silke Hampel, et al.Plos One|July 16, 2014
Lack of ephrin receptor A1 is a favorable independent prognostic factor in clear cell renal cell carcinomaMarieta I Toma, Kati Erdmann, Michael Diezel, et al.Pageof 9